Literature DB >> 4371345

Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy.

W B Malarkey, J Cyrus, G W Paulson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4371345     DOI： 10.1210/jcem-39-2-229

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  10 in total

1.  Long-term effect of ovariectomy on dopamine-stimulated adenylate cyclase in rat striatum and nucleus accumbens.

Authors:  K Kumakura; M Hoffman; D Cocchi; M Trabucchi; P F Spano; E E Müller
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

2.  Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy.

Authors:  H P Vogel; R Ketsche
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

Review 3.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

Review 4.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

5.  Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.

Authors:  A Galea-Debono; P Jenner; C D Marsden; J D Parkes; D Tarsy; J Walters
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-02       Impact factor: 10.154

6.  Bromocriptine treatment in Parkinson's disease.

Authors:  J D Parkes; C D Marsden; I Donaldson; A Galea-Debono; J Walters; G Kennedy; P Asselman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-02       Impact factor: 10.154

7.  Endocrine aspects of bromocriptine therapy in Parkinsonism.

Authors:  K M Shaw; A J Lees; S Franks; P Daggett; B D Thompson; G M Stern
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

8.  Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response.

Authors:  A Agnoli; M Baldassarre; S Ruggieri; P Falaschi; R D Urso; A Rocco
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

Review 9.  The hypothalamus in Parkinson disease.

Authors:  R Sandyk; R P Iacono; C R Bamford
Journal:  Ital J Neurol Sci       Date:  1987-06

Review 10.  The endocrine profile of bromocriptine: its application in endocrine diseases.

Authors:  I Lancranjan
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.